Related Experiment Video
Updated: Jan 21, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
Fibroblast Growth Factor Receptor Functions in Glioblastoma
Ana Jimenez-Pascual1, Florian A Siebzehnrubl2
1European Cancer Stem Cell Research Institute, Cardiff University School of Biosciences, Cardiff CF24 4HQ, UK.
Abstract:
Glioblastoma is the most lethal brain cancer in adults, with no known cure. This cancer is characterized by a pronounced genetic heterogeneity, but aberrant activation of receptor tyrosine kinase signaling is among the most frequent molecular alterations in glioblastoma. Somatic mutations of fibroblast growth factor receptors (FGFRs) are rare in these cancers, but many studies have documented that signaling through FGFRs impacts glioblastoma progression and patient survival. Small-molecule inhibitors of FGFR tyrosine kinases are currently being trialed, underlining the therapeutic potential of blocking this signaling pathway. Nevertheless, a comprehensive overview of the state of the art of the literature on FGFRs in glioblastoma is lacking. Here, we review the evidence for the biological functions of FGFRs in glioblastoma, as well as pharmacological approaches to targeting these receptors.
Insights
Fibroblast growth factor receptors (FGFRs) play a key role in glioblastoma progression. This review covers FGFR functions and therapeutic strategies targeting FGFRs in brain cancer.
Area of Science:
- Neuro-oncology
- Cancer biology
- Molecular signaling
Background:
- Glioblastoma is a lethal adult brain cancer with significant genetic heterogeneity.
- Aberrant receptor tyrosine kinase signaling is common in glioblastoma.
- Fibroblast growth factor receptors (FGFRs) signaling impacts glioblastoma progression and survival, despite rare somatic mutations.
Purpose of the Study:
- To provide a comprehensive review of the current literature on FGFRs in glioblastoma.
- To summarize the biological functions of FGFRs in glioblastoma.
- To discuss pharmacological approaches targeting FGFRs for glioblastoma treatment.
Main Methods:
- Literature review of scientific articles on FGFRs and glioblastoma.
- Analysis of studies detailing FGFR signaling pathways in brain tumors.
- Examination of preclinical and clinical data on FGFR inhibitors.
Main Results:
- FGFR signaling is implicated in glioblastoma pathogenesis and patient outcomes.
- Small-molecule inhibitors targeting FGFR tyrosine kinases show therapeutic potential.
- Targeting FGFRs represents a promising strategy for glioblastoma treatment.
Conclusions:
- FGFRs are significant targets for glioblastoma therapy.
- Further research into FGFR-targeted therapies is warranted.
- Comprehensive understanding of FGFRs is crucial for advancing glioblastoma treatment.
More Related Videos
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: Osmolarity
Population Growth
Transcription Factors

